Budesonide is a glucocorticoid steroid. It is available as an inhaler, pill, nasal spray, and rectal forms. The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form and rectal forms may be used for inflammatory bowel disease including Crohn’s disease, ulcerative colitis and microscopic colitis. It is also used for the treatment of various skin disorders.
It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system.

Sterling holds Certificate of Suitability n. R0-CEP 2009-057-Rev 00 issued by Quality of Medicines & HealthCare (EDQM) on 20/10/2010.

US DMF was submitted to FDA on 19/03/2009 and the following number was assigned n. 22641.